Every coffee keeps the site running. Thank you!
Tech, gaming and the news that matters
Pharmaceutical developers are shortening Phase II and Phase III trial timelines by leveraging machine learning algorithms to screen patient eligibility criteria across integrated health networks.
Operational Efficiency Gain
Traditional patient recruitment accounts for nearly half of total clinical trial durations. Automated parsing of unstructured medical records has reduced enrollment drop-out rates by 22% while improving cohort diversity.
Scales of economy and improved cold-chain capacity are lowering production costs for next-generation metabolic drugs.
Liposuction is the commonest aesthetic procedure performed in India and is used to cure your body fat. A…
If you’re doing. well and good in order to! If not, we’ll must be first discover what is…
Machine learning platforms are demonstrating reduced timelines in lead optimization, with several AI-designed compounds advancing to Phase II…
I know a lot of people are interested in selling their body parts and make money. You are…
Integrating predictive modeling into patient cohort selection reduces trial dropouts and regulatory delays.